RxSight, Inc. (RXST) NASDAQ

8.92

-0.46(-4.90%)

Updated at September 30 01:32PM

Currency In USD

RxSight, Inc.

Address

100 Columbia

Aliso Viejo, CA 92656

United States of America

Phone

949 521 7830

Sector

Healthcare

Industry

Medical - Devices

Employees

498

First IPO Date

July 30, 2021

Key Executives

NameTitlePayYear Born
Dr. Ronald M. Kurtz M.D.Co-President, Chief Executive Officer & Director1.44M1963
Ms. Shelley B. ThunenCo-President & Chief Financial Officer877,3801954
Mr. Eric J. WeinbergCo-President & Chief Commercial Officer877,3801961
Dr. Ilya Goldshleger Ph.D.Co-President & Chief Operating Officer899,8801975
Ms. Caroline VaughnVice President of Human Resources0N/A
Mr. Roy FreemanSenior Vice President of Marketing & Professional Relations0N/A
Mr. Scott GainesExecutive Vice President of Manufacturing & Commercial Operations0N/A
Mr. Oliver MoravcevicVice President of Investor Relations0N/A
Mr. Matt Haller Ph.D.Chief Technology Officer0N/A
Mr. Steve EverlySenior Vice President of Sales of North America0N/A

Description

RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. It primarily serves cataract doctors. The company was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California.